Redx Pharma (REDX) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Mar 2022 12:30 PM
RNS
Result of AGM
02 Mar 2022 07:00 AM
RNS
Redx to Present at Cowen Health Care Conference
28 Feb 2022 07:00 AM
RNS
Redx to Present at ILD Summit 2022
11 Feb 2022 04:43 PM
RNS
Notice of AGM
28 Jan 2022 07:00 AM
RNS
New Grant of Share Options
27 Jan 2022 07:01 AM
RNS
Appointment of Non-Executive Director
27 Jan 2022 07:00 AM
RNS
Final Audited Results and Operational Update
25 Jan 2022 12:00 PM
RNS
Notice of Preliminary Results
23 Dec 2021 07:00 AM
RNS
Redx to Receive Milestone Payment of $9m from AZ
09 Dec 2021 04:41 PM
RNS
Second Price Monitoring Extn
09 Dec 2021 04:36 PM
RNS
Price Monitoring Extension
09 Dec 2021 02:06 PM
RNS
Second Price Monitoring Extn
09 Dec 2021 02:00 PM
RNS
Price Monitoring Extension
09 Dec 2021 07:00 AM
RNS
Redx to receive milestone of $10m from Jazz
06 Dec 2021 07:00 AM
RNS
Redx and Caris Life Sciences Announce Partnership
30 Nov 2021 07:00 AM
RNS
Redx to Participate at Piper Sandler Conference
17 Nov 2021 07:00 AM
RNS
Redx to Present at Jefferies London Conference
15 Nov 2021 07:00 AM
RNS
First Patient Dosed in Phase 2 Trial of RXC004
01 Nov 2021 07:00 AM
RNS
Appointment of Non-Executive Chair
11 Oct 2021 07:00 AM
RNS
R&D Day and New Clinical Data for ROCK2 Inhibitor
05 Oct 2021 07:00 AM
RNS
Redx to host Virtual R&D Day on 11 October 2021
27 Sep 2021 08:00 AM
RNS
Exercise of Options and Total Voting Rights
20 Sep 2021 04:59 PM
RNS
Redx Presents Encouraging Phase 1 Data for RXC004
17 Sep 2021 11:06 AM
RNS
Second Price Monitoring Extn
17 Sep 2021 11:00 AM
RNS
Price Monitoring Extension
16 Sep 2021 12:16 PM
RNS
Price Monitoring Extension
16 Sep 2021 12:15 PM
RNS
Second Price Monitoring Extn
16 Sep 2021 12:12 PM
RNS
Second Price Monitoring Extn
16 Sep 2021 12:08 PM
RNS
Price Monitoring Extension
14 Sep 2021 02:05 PM
RNS
Second Price Monitoring Extn
14 Sep 2021 02:00 PM
RNS
Price Monitoring Extension
14 Sep 2021 11:05 AM
RNS
Second Price Monitoring Extn
14 Sep 2021 11:00 AM
RNS
Price Monitoring Extension
13 Sep 2021 07:00 AM
RNS
RXC004 Phase 1 data to be presented at ESMO 2021
06 Sep 2021 09:05 AM
RNS
Second Price Monitoring Extn
06 Sep 2021 09:00 AM
RNS
Price Monitoring Extension
02 Sep 2021 07:00 AM
RNS
Milestone Payment from Jazz Pharmaceuticals
27 Jul 2021 07:00 AM
RNS
Redx Announces Phase 2 Dose Selection of RXC004
08 Jul 2021 01:43 PM
RNS
Exercise of Options and Total Voting Rights
01 Jul 2021 11:08 AM
RNS
New Grant of Options and Director/PDMR Dealing
17 Jun 2021 07:00 AM
RNS
Redx Receives Milestone Payment for RXC006
07 Jun 2021 07:00 AM
RNS
Interim results for the six months ended 31 March
04 Jun 2021 07:00 AM
RNS
Change of Auditor
03 Jun 2021 07:00 AM
RNS
First Subject Dosed in Phase 1 Study with RXC007
01 Jun 2021 07:00 AM
RNS
Directorate Change
24 May 2021 07:00 AM
RNS
Notice of Interim Results
19 May 2021 07:00 AM
RNS
Appointment of Non-Executive Director
05 May 2021 07:00 AM
RNS
Appointment of Peter Collum as CFO
28 Apr 2021 07:00 AM
RNS
Dosing of first patients with RXC004 and Anti-PD1
29 Mar 2021 09:00 AM
RNS
Redx to present at AACR
UK 100

Latest directors dealings